We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editorial |

Are All Units Created Equal?

Jean Carruthers, MD, FRCSC, FRCS (Ophth)1,2; Alastair Carruthers, MBBS, FRCPC, FRCP (London)2
[+] Author Affiliations
1American Society Ophthalmic Plastic and Reconstructive Surgery, Chicago, Illinois
2University of British Columbia, Carruthers Cosmetic Surgery Inc, Vancouver, Canada
JAMA Dermatol. 2013;149(12):1377. doi:10.1001/jamadermatol.2013.6836.
Text Size: A A A
Published online


With their article in this issue, Hexsel et al1 have made an important and challenging observation. They injected each side of the frontalis muscle with equal unit doses of 2 of the commercially available botulinum toxins—units that most scientists who understand the methods of unit measurement, as well as clinicians who use the toxins, would say are not equal. Their finding that the diffusion halo of onabotulinumtoxinA is greater than the diffusion halo of abobotulinumtoxinA when measured by anhidrosis would seem to confirm that the onabotulinumtoxinA units are more potent than the abobotulinumtoxinA units. However, in their conclusion, the authors focus on the fact that there is no difference between the muscle effects of the 2 products as measured by compound muscle action potential or clinical wrinkle effect. So does this suggest that we need to rethink our view of these “units”? Does it mean that the authors have teased out the separate effects of these 2 neuromodulators on striated muscle and glandular function, or does it confirm a difference in potency?

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections